Sign In

Press release centre

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.

Past Press Releases - CellCentric Ltd.

June 20, 2012
CellCentric and ZoBio Partner to Develop Lead Compounds Against Epigenetic Drug Targets
ZoBio and CellCentric are pleased to announce that the companies are working together to discover lead compounds against CellCentric’s portfolio of epigenetic therapeutic drug targets. More

November 14, 2007
CellCentric and Cancer Research Technology collaborate on epigenetic discoveries
New alliance will accelerate the validation of novel epigenetic targets and the generation of therapeutic product candidates from the lab of Tony Kouzarides. More

October 2, 2007
CellCentric receives funding from Takeda Research Investment, Inc.
Existing shareholders including Morningside and NESTA contribute to Series A fund alongside the endorsement from a corporate pharmaceutical investor More

September 26, 2005
CellCentric and Cancer Research Technology initiate co-development partnership
CellCentric, a leading company in the exploitation of epigenetics and Cancer Research Technology Ltd (CRT), the specialist oncology commercialisation and development company announce that they have begun an anti-cancer co-development programme.


Tech investments
From our Online Data Service
VC-backed companies
From our Radar

Recent Deals

Nov 25€24.0MInternet commerce
Mar 23€2.0MInternet services
Mar 23€1.5MInternet services
Mar 23€110.0MInternet commerce
Mar 21€1.9MBusiness applications
Mar 20€1.0MInternet commerce
Mar 20€12.0ME-Commerce

For information on Europe's most extensive database on technology funding click here!


Press Releases

May 28
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
nethone raised over $1 million from innovation nest

Jan 29
yumpingo raises $10m to transform guest experiences in restaurants

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.